Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0000950170-24-099481

Chief Scientific Officer sold 16,496 shares at $2.96 ($48,883)

  • Chief Scientific Officer acquired 16,496 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SCIASCIA THOMAS · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-19 Exercise or conversion : show line 1 in the form +16,496 $1.43 $23,589 236,811 D
2024-08-19 Sale : show line 2 in the form −16,496 $2.96 $48,883 220,315 D
Open-market sales · 16,496 sh · avg $2.96 · $48,883

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-19 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −16,496 0 D
Loading xslF345X05/ownership.xml…